ASAndrew H. Schlueter

Andrew H. Schlueter

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andrew H. Schlueter has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Inducible haemorrhage (epistaxis) secondary to lomustine administration without thrombocytopenia in a dog

    by Andrew Schlueter, Rance Sellon

    A 13‐year‐old dog with no history of spontaneous bleeding was presented for evaluation of multiple diffusely distributed cutaneous mast cell tumours. No obvious metastasis was found, and chemotherapy with vinblastine/lomustine was initiated. After the second dose of lomustine was administered, the dog experienced epistaxis for 2–3 minutes per day along with heavy sneezing due to the discharge. Throughout additional chemotherapy cycles, intermittent nasal bleeding continued, and investigation into the causes of epistaxis found no obvious nasal causes or coagulopathies, but epistaxis resolved after lomustine administration was delayed. As the mast cell tumours began to grow again, another dose of lomustine was given without vinblastine, and epistaxis returned. Throughout the dog's treatment, it was never thrombocytopenic but often had thrombocytosis. There are reports of lomustine and other nitrosoureas affecting platelet function in people, and this could be considered a differential in dogs as well.

  • Open Access

    Treatment of feline oral squamous cell carcinoma with accelerated radiation and carboplatin with and without follow-up toceranib phosphate

    by Andrew Schlueter, Camille Hanot, Rance Sellon, Janean Fidel

    Objectives: Oral squamous cell carcinoma (SCC) is the most common oral tumor in cats but treatment options that provide long-term tumor control are limited. Radiation therapy is a reported treatment option, but local tumor control is still difficult to obtain and additional treatment options are needed. Toceranib phosphate recently emerged as having biologic activity against feline oral SCC. This study is a preliminary evaluation of radiation therapy and toceranib phosphate in cats with oral SCC. Methods: This non-blinded, retrospective, single-institutional study included all patients between 2011 and 2023 that underwent the same treatment with accelerated radiation therapy and concurrent carboplatin as previously described, with the exception of one additional fraction of radiation. Once the early side effects abated, toceranib phosphate was offered as follow-up maintenance therapy. The median survival time (MST) and progression-free interval (PFI) were assessed for the cats that received toceranib after radiation therapy and carboplatin, and were compared with the cats that received the same radiation and carboplatin protocol within the same time period but did not receive follow-up toceranib. Results: Overall, 47 cats met the criteria for evaluation; of them, 15 received follow-up toceranib. The MST of all cats was 164 days; there was no significant difference in MST or PFI between the cats that did and did not receive adjuvant toceranib (MST 208 days vs 162 days, respectively; P = 0.35). When comparing cats with lingual tumors, the PFI was significantly longer in the cats that received toceranib than those that did not (142 days vs 104 days, respectively; P = 0.045); however, there was no difference in MST (197 days vs 147 days; P = 0.15). Conclusions and relevance: This study suggests that most cats with oral SCC do not benefit from toceranib after radiation therapy. There may be clinical benefit to administering adjuvant toceranib after radiation in cats with lingual SCCs, but the mechanism remains unclear and additional studies are warranted.


  • Feline mesothelioma: case report and review of cytologic, immunocytochemical, histopathologic, and immunohistochemical findings

    by Andrew H. Schlueter, Shannon D. Dehghanpir, Bonnie Boudreaux, Christopher Robinson, Jose Cesar Menk P. Lima, Ingeborg M. Langohr

    Mesotheliomas are uncommon neoplasms that arise from mesothelial cells in either the abdominal or thoracic cavities and are rarely diagnosed in cats. A 10-y-old spayed female domestic shorthair cat was presented to the Louisiana State University oncology service for evaluation of a large amount of abdominal effusion. Abdominal ultrasound identified a large mesenteric mass with numerous ill-defined nodules. An abdominocentesis was performed with cytologic and immunocytochemical findings consistent with a neoplastic effusion, with large clusters of epithelioid cells that exhibited strong cytoplasmic expression of pancytokeratin, vimentin, and Wilms tumor 1 antigens. Further testing was declined, and meloxicam was prescribed until the cat died 23 d after initial presentation. Upon postmortem examination, the omentum was contracted into a firm mass adhered to multiple organs and accompanied by numerous small white nodules throughout the abdominal cavity. On histopathology and immunohistochemistry, neoplastic cells were found throughout the abdominal cavity; 60–95% exhibited moderate-to-strong cytoplasmic immunoreactivity for cytokeratin, vimentin, and Wilms tumor 1 protein. The final diagnosis was an epithelioid mesothelioma. Our case illustrates the utility of cytology, immunocytochemistry, and its relation to histology and immunohistochemistry. We also reviewed the reported cases of feline mesothelioma.


  • Open Access

    Rhabdochlamydia spp. in an Oregon raptor

    by Sophie J. Jouffroy, Andrew H. Schlueter, Robert J. Bildfell, Daniel D. Rockey

    PCR-based approach was used to examine the rate of Chlamydia positivity in raptors from wild bird rehabilitation centers in Oregon. Three of 82 birds were identified as positive for Chlamydia with this PCR. Sequence analysis of 16S ribosomal DNA from 2 of these birds confirmed the presence of DNA from phylum Chlamydiae. One bird was positive for Chlamydia psittaci in both choanal and cloacal swabs. The second bird, a louse-infested red-tailed hawk, had evidence of choanal colonization by “Candidatus Rhabdochlamydia” spp. Our study describes evidence of this Chlamydia-like organism in the United States. This survey also suggests that the carriage rate of C. psittaci is low in raptors in Oregon wild bird rehabilitation centers, and that care must be taken in the design of PCR primers for phylum Chlamydiae such that colonization by insect endosymbionts is not mistaken for an infection by known chlamydial pathogens.